Back to Search
Start Over
Patent Issued for Ophthalmic composition for treatment of dry eye disease (USPTO 12059449).
- Source :
- Pharma Business Week; 9/2/2024, p4038-4038, 1p
- Publication Year :
- 2024
-
Abstract
- The article focuses on a newly issued patent for an ophthalmic composition aimed at treating dry eye disease. Topics include the use of 0.1% cyclosporine dissolved in 1-(perfluorobutyl)pentane, the method of topical administration, and the composition's effectiveness in improving tear production and alleviating dry eye symptoms.
Details
- Language :
- English
- ISSN :
- 15436675
- Database :
- Complementary Index
- Journal :
- Pharma Business Week
- Publication Type :
- Periodical
- Accession number :
- 179334307